Pill with high potency progestogen protects against cancerBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7329.69 (Published 12 January 2002) Cite this as: BMJ 2002;324:69
- David Spurgeon
Oral contraceptives with a higher progestogen potency lead to a greater reduction of risk of ovarian cancer than those with lower progestogen potency, says a new study in the US Journal of the National Cancer Institute (2002;94:32-6). This was regardless of the oestrogen content in the pills and how long they were used for.
The study, from Duke University Medical Centre in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial